Searched for
CENTRE FOR CANCER IMMUNOLOGY
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Novartis bets big on India; looks to grow beyond cost arbitrage to high-value innovationNovartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...
- Hospital stocks: Short-term headwinds an opportunity? 10 stocks from the healthcare sector with an upside potential of up to 35%This may not have made it to the headlines, but for the last few months a tussle has been going on between health insurance companies and h...
- Healthcare stocks: Better to own a basket for a healthy portfolio? 15 healthcare stocks with an upside potential of up to 33%Four years ago, Covid brought hospital stocks to the limelight. Since then, corporate actions like mergers and takeovers have kept them in ...
- Heartbeat unplugged: Addressing the silent epidemic of cardiovascular diseases through an Indian perspectivePrevention is key, and it's essential to address risk factors before symptoms develop when it comes to cardiovascular diseases, which is wh...
- Karnataka to unveil new IT policy next weekThe new IT policy would focus on tier-2 and 3 cities, Narayan indicated, adding the government would strengthen educational institutions to...
- Lupin developing new products to treat cancer, other diseasesSharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...
- Indian scientists make their meeting with Nobel heroes countThe meeting offers researchers an opportunity to closely interact with Nobel laureates from their discipline over seven days.
- Our aim is to be among top 10 players in India: Rajiv Malik of MylanThe Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases such as HIV and tuberculosi...
- Ayushman plan brilliant move; India needed it, says Rajiv Malik, President, MylanThe Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases like HIV and tuberculosis, ...
- Govt seeks to define stem cells as drug, regulate use in therapyThe ministry defined the category of stem cells and their derivatives that would be termed a drug, and would thereby have to follow the pro...
- Forced to return from the US, jobless research scientist drags Centre to Bombay High CourtThe bench said it will hear the matter, but Noothi's lawyer Rahul Totala moved a separate plea to tag his matter with another case pending ...
- 30% green tax on diesel vehicles?The Environment Pollution Control Authority (EPCA) has suggested that a green tax of 30% be imposed on diesel vehicles to check their numbe...
- We are beginning to treat cancer in a whole new way: ScientistsRather than killing cancer cells directly with chemo , the latest treatments are designed to promote the body's natural immune control over...
- India head of Mills and Boon branch pens novel on cyber crime, IP lawsA new book by Amrita Chowdhury, country head of Mills and Boon subsidiary Harlequin India, is a blend of cyber crime, medical ethics and IP...
- Affordable innovation in healthcareAffordable innovation is the only way forward, and India has a unique opportunity to deliver it to global markets by building excellence ac...
- Biogen for inlicensing deal with Indian cosUS-based biotech company Biogen Idec, is looking for partnerships across the pharma value chain, including in-licensing of new experimental...
Load More
